Health
Assessing mRNA Cancer Vaccine
Experts discuss the latest developments in Merck and Moderna’s mRNA cancer vaccine at the annual meeting of the European Society for Medical Oncology. The research could have significant implications for future cancer treatments.
Coverage timeline — 1 article
STAT News
On this week's “The Readout LOUD,” we discuss the latest cancer data presented at the annual meeting of the European Society for Medical Oncology.
2026-10-30 13:33 UTC